The Cancer Trial Healing Portfolio Pains

Early-stage trial data is turning heads after revealing that a novel cancer therapy may significantly boost drug exposure without amplifying side effects.

For investors, this could mark a pivotal shift in the company’s long-term trajectory.

A destructive new force Elon Musk warns is America’s “scariest problem” threatens to impoverish millions… while creating a potential fortune for a handful of others

Watch now – discover how to get your money on the right side of the brutal divide

Wall Street closed lower as Oracle’s datacenter setback rattled AI names, weighing on sentiment across tech.

Fed Governor Waller signaled patience on rate cuts despite soft jobs data, while weak economic readings added pressure ahead of Thursday’s CPI.

Ford (NYSE: F) has slammed the brakes on its electric vehicle expansion, triggering shockwaves that now ripple far beyond Detroit.

The $6.5 billion pivot is sharp enough that you start seeing consequences not just inside Ford, but across the global battery supply chain that was built for nonstop EV growth.

Capital is being redirected toward gas-powered trucks and hybrids, while large-scale EV programs are being narrowed or shelved.

In the middle of that shift, you find multiyear battery contracts quietly unwinding almost overnight.

Battery Dreams Meet Reality

Major battery supply agreements tied to electric trucks and commercial EVs have been canceled, removing the demand that factories were built to serve.

Entire production schedules are now being rewritten, and you are watching capacity once meant for vehicles search for new homes.

One joint venture has already been dissolved, leading to layoffs at a U.S. battery plant.

Former partners are pivoting toward energy storage and AI data center projects instead of transportation.

A Message the Industry Can’t Ignore

Inside Ford, the strategy is now about flexibility and profitability rather than scale at any cost.

EVs remain part of the future, but you can see the company refusing to subsidize growth that does not pencil out.

This reset does not just redefine Ford’s roadmap.

It forces the entire auto and battery industry to rethink timelines, economics, and how fast electrification can realistically move from promise to profit.

Walmart (NYSE: WMT) is now caught in the middle of a nationwide impersonation scam that is spreading at an alarming rate.

Fraudsters are placing automated robocalls every week, and you hear Walmart’s name used as the hook to trigger panic over fake high-value purchases.

The calls impersonate Walmart employees and push victims to confirm charges tied to electronics and gift cards.

Once that pressure hits, you see personal and financial data handed over before suspicion has time to catch up.

Why Scale Makes This So Dangerous

The scheme works because Walmart’s brand carries instant credibility across every income level. When you receive a call tied to a retailer you already shop with, hesitation drops fast.

This is not a small operation running in isolation.

The volume points to industrialized fraud using AI voices, scripted flows, and real-time response systems designed to move faster than consumer awareness.

Trust Is Now a Front-Line Asset

For Walmart, the fallout extends beyond customer complaints and call-center strain.

Every successful scam chips away at confidence, and you can feel how quickly confusion spreads even when the company itself is not responsible.

This episode highlights a broader shift facing major retailers. Defending price, inventory, and logistics is no longer enough when brand identity itself becomes a target at scale.

Walmart’s response now sits at the intersection of fraud detection, customer education, and digital trust.

In today’s retail environment, protecting the name is inseparable from protecting the business.

Every market cycle produces a select group of companies that drastically outperform the rest.

The latest screening has pinpointed the 5 Stocks Set to Double, each showing rare traits linked to early stage momentum.

These names carry the same type of indicators that have historically appeared ahead of strong rallies.

Earlier reports featured stocks that delivered +175%, +498%, and +673%.

Get the Free 5 Stocks Set to Double Report.

Amazon (NASDAQ: AMZN) is quietly exploring a move that could reshape the AI landscape, holding early-stage talks to invest more than $10 billion into OpenAI.

The scale matters because it signals Amazon wants influence at the foundation layer, not just exposure to AI demand.

Beyond capital, the discussions include OpenAI training models on Amazon's Trainium chips, a detail that changes the power balance.

In this shift, you start seeing Amazon push its own hardware into workloads that usually run on Nvidia.

Turning AWS Into the Default AI Backbone

For Amazon, this is not about one partnership; it is about reinforcing AWS as the core platform for generative AI.

A deeper OpenAI relationship would strengthen AWS's positioning against Microsoft Azure and Google Cloud at a time when enterprises are choosing long-term AI homes.

As compute costs surge, you see AWS aiming to lock in anchor clients early, while you watch rivals fight for the same workloads.

Control over chips, cloud, and capital creates leverage that few competitors can match.

Why the Timing Is Everything

AI demand is accelerating faster than infrastructure can keep up, making early commitments decisive.

OpenAI represents one of the largest and most stable long-term compute consumers in the world.

If this deal moves forward, you are not just watching another expansion from Amazon.

You are standing at the point where the company starts deciding the physical paths AI will rely on for years to come.

👉 Click here to get our closing report to your cell for free!

Processa Pharmaceuticals Inc [PCSA] $6.68 (+122.30%)

Processa surged after early Phase 2 data showed its NGC‑Cap therapy boosted cancer‑killing drug exposure without increasing severe side effects.

Dbv Technologies [DBVT] $22.47 (+24.97%)

DBV Technologies soared after its Phase 3 VITESSE trial met the primary endpoint, clearing the path toward a 2026 BLA for its peanut allergy patch.

Beneficient [BENF] $4.58 (+22.58%)

Beneficient rose after appointing a seasoned former EY partner as Board Chairman, strengthening governance and long‑term strategic credibility.

Children's Place Inc [PLCE] $4.64 (-36.87%)

Children's Place Inc dropped after a 13% revenue decline and a surprise quarterly loss exposed deeper e‑commerce and margin issues despite turnaround efforts.

Kyverna Therapeutics Inc [KYTX] $6.91 (-32.52%)

Kyverna declined after pricing a $100 million public offering at a 30% discount to recent levels, triggering dilution concerns.

Spire Global Inc [SPIR] $7.02 (-24.33%)

Spire dipped after revenue missed expectations and losses widened, with some key contract revenue delayed into 2026.

The next leg of AI growth is set to emerge from advanced data infrastructure, a segment gaining powerful momentum beneath the surface.

Leaders in this space are showing strong operational expansion, increasing government interest, and growing enterprise adoption.

These developments are quietly creating high-probability setups for early movers.

As demand accelerates, positioning inside this sector could produce significant compounding potential.

A FREE report highlights all nine opportunities poised to benefit from this surge.

Download your FREE Report Now.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.